ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹46 Cr | ₹44 Cr | ₹49 Cr | ₹59 Cr | ₹49 Cr |
What is the latest Total Non-Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹46 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹59 Cr |
| Mar2021 | ₹49 Cr |
How is Total Non-Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹46 Cr | 4.54 | |
| Mar2024 | ₹44 Cr | -10.30 | |
| Mar2023 | ₹49 Cr | -17.87 | |
| Mar2022 | ₹59 Cr | 20.87 | |
| Mar2021 | ₹49 Cr | - | |
Compare Total Non-Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,339.1 Cr | 9.7% | 3.1% | -16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 9.7% |
3.1% |
-16.2% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses